drugset / Trial / NCT06650761
A Phase I Study of CDX-622
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a study to determine the safety of CDX-622 in healthy participants.
Timeline
- Start
- 2024-11-01
- Primary completion
- 2026-04-24
- Completion
- 2026-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CDX-622 | Unknown | — | Intravenous |
Indications
No indication recorded.